Drug for further processing · DRUG FOR FURTHER PROCESSING
Erythromycin NDC 0093-5571
Erythromycin 250 mg/1 · Tablet, Film coated · Teva Pharmaceuticals USA, Inc.
Unfinished product
This listing is a drug for further processing, not a finished drug product dispensed or administered to patients. It is not normally billed.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0093-5571-99 | 00093557199 | 17130 TABLET, FILM COATED in 1 CONTAINER (0093-5571-99)Marketed from 12-FEB-21 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Generic name (nonproprietary)
- erythromycin
- Active ingredients
- Erythromycin — 250 mg/1
- Dosage form
- Tablet, Film coated
- Product type
- Drug for further processing
- Marketing category
- Drug for further processing
- Marketing start
- Listing expires
- Identifiers
- Product ID 0093-5571_8cd80b69-b7f5-4779-8e6f-10c9a129449eSPL ID 8cd80b69-b7f5-4779-8e6f-10c9a129449e
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400093557199followed by a unit qualifier and the quantityPackage 00093-5571-99. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.